Jackson C, Crossland L, Dennis M, Wardlaw J, Sudlow C
Division of Clinical Neurosciences, University of Edinburgh, Bramwell Dott Building, Western General Hospital, Edinburgh, EH4 2XU, UK.
QJM. 2008 Apr;101(4):281-9. doi: 10.1093/qjmed/hcm152. Epub 2008 Feb 15.
Increasing regulation of medical research, in particular the requirement for explicit consent, may reduce the quantity and quality of clinical epidemiological research.
To assess the potential biases arising from the need for explicit consent in our hospital-based stroke research register.
Comparison of patients enrolled into our stroke research register with those included in a concurrent clinical stroke audit that targeted the same population but did not require explicit consent.
We obtained the numbers of consenters, refusers and those from whom consent was not sought for various logistical reasons. We compared characteristics of participants (those eventually included in the research register) vs. non-participants.
Of 1228 patients included in the stroke audit during an 18-month period, 1075 (88%) were also included in the research register, with higher participation among outpatients than inpatients. Only 1% of eligible patients refused involvement in any aspect of the research register. By far the largest number of non-participants was those from whom we could not seek consent for practical reasons. Comparison of baseline characteristics showed important differences between participants and non-participants that could affect outcome.
Very few patients refused inclusion in our research register, but the need for explicit consent reduced participation and introduced bias. An opt-out system avoiding the need for explicit patient consent for minimally intrusive clinical epidemiological studies would minimize bias and reduce the considerable time and costs associated with the consent process.
对医学研究的监管日益加强,尤其是对明确同意的要求,可能会降低临床流行病学研究的数量和质量。
评估在我们基于医院的卒中研究登记中,因需要明确同意而产生的潜在偏倚。
将纳入我们卒中研究登记的患者与同时进行的针对相同人群但不需要明确同意的临床卒中审核中纳入的患者进行比较。
我们获取了同意者、拒绝者以及因各种后勤原因未寻求同意者的数量。我们比较了参与者(最终纳入研究登记的患者)与非参与者的特征。
在18个月期间纳入卒中审核的1228例患者中,1075例(88%)也被纳入了研究登记,门诊患者的参与率高于住院患者。只有1%的符合条件的患者拒绝参与研究登记的任何方面。到目前为止,非参与者中数量最多的是那些因实际原因我们无法寻求同意的患者。基线特征的比较显示参与者和非参与者之间存在可能影响结果的重要差异。
很少有患者拒绝纳入我们的研究登记,但明确同意的要求降低了参与率并引入了偏倚。对于侵入性最小的临床流行病学研究,采用无需患者明确同意的退出系统将使偏倚最小化,并减少与同意过程相关的大量时间和成本。